A pilot program from MultiCare Deaconess Hospital now provides long lasting opioid withdrawal medication. The injectable buprenorphine will provide a much more stable basis for patients to ...

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...

The findings, which appeared today in JAMA Network Open, are strong evidence that buprenorphine, a medication approved by the U.S. Food and Drug Administration to treat opioid use disorder, can be ...

Please provide your email address to receive an email when new articles are posted on . The study included 227 individuals with OUD given CAM2038 either on weekly or monthly basis. The treatment was ...

Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

Aug. 23, 2005 — Anesthesia-assisted rapid detoxification from heroin offers no advantages over an approach using buprenorphine, according to the results of a randomized trial reported in the Aug.

This is particularly true among fentanyl-dependent individuals, many of whom report that buprenorphine initially makes their symptoms worse before abating. Withdrawal symptoms of ...